Modulation of Erm methyltransferase activity by peptides derived from phage display

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1961-1963

  Giannattasio, Robert B ^a   Weisblum, Bernard ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; ENZYME INHIBITOR; ERM METHYLTRANSFERASE; METHYLTRANSFERASE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME INHIBITION; IC 50; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN METHYLATION; STREPTOMYCES FRADIAE;

BACILLUS SUBTILIS; CATALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; METHYLATION; METHYLTRANSFERASES; PEPTIDE LIBRARY; PEPTIDES;

EID: 0033919996     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1961-1963.2000     Document Type: Article

References (9)

1. Bussiere, D. E., S. W. Muchmore, C. G. Dealwis, G. Schluckebier, V. L. Nienaber, R. P. Edalji, K. A. Walter, U. S. Ladror, T. F. Holzman, and C. Abad-Zapatero. 1998. Crystal structure of ErmC', an rRNA methyltransferase which mediates antibiotic resistance in bacteria. Biochemistry 37: 7103-7112.
2. Clancy, J., B. J. Schmieder, J. W. Petitpas, M. Manousos, J. A. Williams, J. A. Faiella, A. E. Girard, and P. R. McGuirk. 1995. Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J. Antihiot. 48:1273-1279.
3. Hajduk, P. J., J. Dinges, J. M. Schkeryantz, D. Janowick, M. Kaminski, M. Tufano, D. J. Augeri, A. Petros, V. Nienaber, P. Zhong, R. Hammond, M. Coen, B. Beutel, L. Katz, and S. W. Fesik. 1999. Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J. Med. Chem. 42: 3852-3859.
4. Kovalic, D., R. B. Giannattasio, H. J. Jin, and B. Weisblum. 1994. 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TIrA) methyltransferase. J. Bacteriol. 176:6992-6998.
5. Schluckebier, G., P. Zhong, K. D. Stewart, T. J. Kavanaugh, and C. Abad-Zapatero. 1999. The 2.2 Å structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism. J. Mol. Biol. 289:277-291.
6. Sparks, A., N. Adey, S. Cwirla, and B. K. Kay. 1996. Chapter 13, p. 227-253. In B. K. Kay, J. Winter, and J. McCafferty (ed.), Phage display of peptides and proteins: a laboratory manual. Academic Press, San Diego, Calif.
7. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585
8. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicroh. Agents Chemother. 39:797-805.
9. Yu, L., A. M. Petros, A. Schnuchel, P. Zhong, J. M. Severin, K. Walter, T. F. Holzman, and S. W. Fesik. 1997. Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance. Nat. Struct. Biol. 4:483-189.